Genealogy Inc. is a global molecular diagnostics company, headquartered in Silicon Valley, with an R&D center in Seoul, South Korea that commercializes disruptive technologies for clinical and research laboratories. Genealogy’s flagship product, microHLA, is the world’s leading microarray-based HLA genotyping product that delivers the most accurate high-resolution HLA genotyping available. Genealogy’s software, ImmunoPlan analyzes data from any sequencing technology and determines HLA genotypes from Whole Exome/Genome Sequencing experiments.
Our Research and Development Team have a mixture of experience in all aspects of molecular diagnostics, with experts in software development, bioinformatics and genomics. Professor Buhm Han, Chief Technology Officer of Genealogy, is one of the pioneers of microarray for HLA, and the inventor of the microHLA. Our major collaborators and key opinion leaders in the HLA community have provided the highest level of leadership within the community for several decades and Genealogy has evolved into a global molecular diagnostics company that currently focuses on driving the adoption of microarray and low-pass NGS in the clinic with ImmunoPlan, the world’s best SNP-based HLA genotyping Assay and Software product.
Genealogy is a people-first company. We strive to create a unique, engaging work environment that fosters the kind of loyalty and long-term commitment that makes for consistently happy employees and clients. Our leadership team is made up of people who epitomize this aspiration.
Leading genomics company that offers the most cost-efficient silico HLA typing solution